Pulmonary Arterial Hypertension

PAH and Connective Tissue Disease (CTDs)

PAH is a common and fatal complication of CTDs. The exact pathophysiological process of PAH is yet to be determined, but is characterised by vascular remodelling within pulmonary arteries resulting from endothelial injury, which in CTDs is probably caused by the systemic disease itself. Read more

PAH and Connective Tissue Disease (CTDs)

Editor's Choice

  • Role of Inhaled Iloprost
    Pulmonary arterial hypertension (PAH) encompasses a group of disorders in which vascular obliteration at the level of the small pulmonary arteries results in progressive elevation of the pulmonary...
  • Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease
    Due to tremendous developments in cardiac surgery, nearly 90% of all children with congenital heart disease reach adult age. In patients with congenital heart disease, pulmonary arterial hypertension...
more

Upcoming events

Cardiovascular Disease Prevention 2009: Seventh Annual Comprehensive Symposium

5th - 7th February 2009

We are pleased to announce the Cardiovascular Disease Prevention 2009 A key strategy for addressing cardiovascular heart...

World Congress of Internal Medicine

20th - 25th March 2010

WCIM 2010 and Physicians Week, will offer a stimulating educational program with many networking opportunities with your peers and a chance to keep...

more

Latest News

27th November 2008 - International Medical Team Announces Patient Results In Adult Stem Cell Clinical Study For Pulmonary Hypertension
26th November 2008 - Why Does It Take So Long For A Correct Diagnosis Of Pulmonary Hypertension?
29th October 2008 - Gilead Announces 2-Year Clinical Data For Letairis® (Ambrisentan) For Treatment Of Pulmonary Arterial Hypertension
9th October 2008 - Early Data Show Potential For Imatinib Mesylate Tablets To Treat Life-Threatening Form Of Pulmonary Artery Disease
more